搜索筛选:
搜索耗时1.8236秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
发布年度:
[期刊论文] 作者：Yong Yuan,Shengzhi Wang,Wenmiao Wang,Cheng Zhu,
来源：国际煤炭科学技术学报（英文版） 年份：2021
It is difficult to accurately calculate the lump coal rate in a fully mechanized mining face.Therefore,a numerical simulation of the coal wall cutting process,which revealed the crack expansion,development,evolution in the coal body and the......
[期刊论文] 作者：Cheng Zhu,Yong Yuan,Wenmiao Wang,Zhongshun Chen,Shengzhi Wang,Huiwei Zhong,
来源：矿业科学技术学报:英文版 年份：2021
The\"three shells\"cooperative support technology was proposed herein according to both the large deformation of the rock surrounding large-section chambers in deep mines and the precarious stability of the support structures therein.The de......
[期刊论文] 作者：Cheng Zhu,Yong Yuan,Wenmiao Wang,Zhongshun Chen,Shengzhi Wang,Huiwei Zhong,
来源：矿业科学技术学报（英文版） 年份：2021
The“three shells”cooperative support technology was proposed herein according to both the large defor-mation of the rock surrounding large-section chambers in...
[期刊论文] 作者：LI Xianxian,TAN Tiening,ZHANG Jian,ZHANG Nan,HE Jianwei,HAN Wenmiao,WANG Yadong,PAN Mu,
来源：武汉理工大学学报（材料科学版）（英文版） 年份：2020
In order to overcome the problem that the low conductivity and high content of graphitic N will lead to serious irreversible capacity loss, magnesiothermic denitriding method was employed to fabricate nitrogen deficient g-C3N4 (ND-g-C3N4). ......
Phase Ⅱ study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative m
[期刊论文] 作者：Anjie Zhu,Peng Yuan,Nanlin Hu,Mingzhou Li,Wenmiao Wang,Xue Wang,Jian Yue,Jiayu Wang,Yang Luo,Fei Ma,Pin,
来源：癌症生物学与医学（英文版） 年份：2021
Objective: Apatinib is an oral TKI targeting VEGFR-2. Single-agent apatinib treatment has been shown to produce an objective response in patients with pretreate...
Phase Ⅱ study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative m
[期刊论文] 作者：Anjie Zhu,Peng Yuan,Nanlin Hu,Mingzhou Li,Wenmiao Wang,Xue Wang,Jian Yue,Jiayu Wang,Yang Luo,Fei Ma,Pin,
来源：癌症生物学与医学:英文版 年份：2021
Objective:Apatinib is an oral TKI targeting VEGFR-2.Single-agent apatinib treatment has been shown to produce an objective response in patients with pretreated m BC.Oral vinorelbine also holds promise as a treatment of choice in patients wi......
相关搜索：
